| Name | Title | Contact Details |
|---|
whites shrimp dock is a Saint Helena Island, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alter G Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Fremont, CA. To find more information about Alter G Inc, please visit www.alter-g.com
People come to Murad when they`re ready to transform the life of their skin. Murad guarantees that transformation because only Murad combines advanced scientific research and practical clinical experience to create high performance skincare products, dietary supplements and lifestyle programs that help people look and feel their absolute best. As America`s first authentic doctor-developed brand, Murad remains true to the scientific principles of its founder, world-renowned dermatologist Howard Murad, M.D. Shaped by his Inclusive Health philosophy and inspired by the real problems of the more than 50,000 patients and clients who have visited his Los Angeles dermatology practice and Inclusive Health Spa®, his award-winning formulas have helped millions to resolve their skin issues. Through more than fifty years of research, Dr. Murad has established that beauty and health are vitally linked and best achieved through an Inclusive approach that improves every cell in the body. The result? The Murad Glow!
SimonMed Imaging is one of the largest outpatient medical imaging providers and largest physician radiology practices in the United States. Our practice consists of over 200 highly-experienced subspecialty-trained radiologists, and we operate across 9 states with over 150 accredited facilities that are ACR-RADSITE certified with certified technologists and equipment. We specialize in using the newest diagnostic imaging technologies and bringing them to the community in an affordable and accessible way. Our logo See Tomorrow Today recognizes that new technology can help provide a more accurate diagnosis but needs to be readily available and affordable.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.